HSPA9 and neoplasm: In this study, we demonstrated that dual targeting GRP75 and HSP90 can also confer potent anti-tumor effect against cancer, which provide one more therapeutic strategy for liver cancer therapy in addition to dual inhibition of HSP70 and HSP90.